InvestorsHub Logo
Followers 840
Posts 121034
Boards Moderated 9
Alias Born 09/05/2002

Re: DewDiligence post# 20

Thursday, 05/04/2023 4:41:42 PM

Thursday, May 04, 2023 4:41:42 PM

Post# of 45
ALGS 1Q23 results—3/31/22 cash=$104M, down from $126M at 12/31/22:

https://finance.yahoo.com/news/aligos-therapeutics-reports-recent-business-200500905.html

ALGS expects to start a phase-1 trial of ALG-097558, a SARS-CoV-2 protease inhibitor, in the UK in mid 2023.

No CC.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume: 11
Day Range:
Bid: 30.90
Ask: 35.00
Last Trade Time: 5:29:31 AM EST
Total Trades: 6
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ALGS News